Body Politics
With national and European associations vying for GPs’ membership fees, they must fight for critical mass and, more crucially, relevance in an ever-changing industry.
Real Deals
Subscribe to Real Deals
For essential market intelligence, deal information and insight from the independent voice of European private equity.
Error: 404
Failbook
A final thought from Carlyle’s David Rubenstein, as featured on CNBC.
Asset class for dummies
What is it that industry associations do? That is the gist of our cover article.
Lion's folk tail
In the Guardian’s write-up of the Weetabix deal, Lion Capital’s Lyndon Lea was described as a “flamboyant venture capitalist” – one out of three ain’t bad.
China crisis
Lion Capital’s recent sale of Weetabix to China’s Bright Food led to plenty of coverage in the mainstream UK press, and it was interesting to see their different takes on the deal.